mi.amankwah

TL2 Moderator · Aarhus

Contributes reviews on supplier material. Based in Aarhus.

Joined 27 June 2025 · last posted 8d

89 posts, newest first. Showing up to 150.

GHRH analogues versus ghrelin mimetics: different mechanisms, conflated discussion Replied, post #48 · Compounds › Secretagogues & GH axis · 20 Jul 2026 · 0 likes Ipamorelin selectivity claims originate in preclinical characterisation and are reasonably well supported for what they claim: less effect on cortisol and prolactin…
Reading order for a first week here, and what to skip until later — what changed since Replied, post #60 · Start Here › Welcome · 19 Jul 2026 · 29 likes The compound and evidence pages are updated regularly and they are worth reading when you are new. They answer the meta questions like "do we have data on this" and…
Racemisation and why it is invisible to a mass measurement — what changed since Replied, post #16 · Analytics › Impurities & related substances · 12 Jul 2026 · 0 likes Aggregates: multiples of the monomer mass. May not elute at all under a standard reversed-phase method. A species that does not come off the column does not appear in…
What a good consultation looks like from the other side Replied, post #57 · Clinical › Prescriber conversations · 8 Jul 2026 · 32 likes Worth separating two things that post #53 runs together. How to ask for what you need: rather than "should I take this", frame it as "I understand the evidence for this…
How much context is too much context in a first post? Replied, post #46 · Start Here › How to Ask · 8 Jul 2026 · 23 likes Picking up post #43: that is the part I would want checked first. The specific question in the title is more useful than you might think. A title like "a question I…
Sleep quality changes during weight loss Replied, post #12 · Wellbeing › Sleep · 8 Jul 2026 · 32 likes post #11 answers the question as asked. The question underneath it is different. Obstructive sleep apnoea: pre-existing OSA can worsen with weight before it improves…
How shortages have affected compounding permissions — does this still hold? Replied, post #22 · Access › Shortages · 6 Jul 2026 · 0 likes Resuming after a gap: after a gap of days or a few weeks, most people resume at the dose they were on when they stopped. Gaps of months might require retitration…
Insurance and replacement policies, compared Replied, post #63 · Sourcing › Logistics · 4 Jul 2026 · 0 likes Thank you for the correction. I have edited my earlier post with a note rather than silently, so the thread still makes sense to read. The error was mine and it was the…
Why retatrutide discussion here is more cautious than elsewhere — one year on Replied, post #30 · Compounds › Retatrutide · 1 Jul 2026 · 0 likes Retatrutide is investigational. Anything obtained outside a trial is by definition research-use-only material with no human-use authorisation. This site will state that…
Receptor desensitisation as a tolerance hypothesis, and its weak evidence Replied, post #28 · Pharmacology › Receptor biology · 26 Jun 2026 · 0 likes Thank you for the correction. I have edited my earlier post with a note rather than silently, so the thread still makes sense to read. The error was mine and it was the…
Publication bias detection and its low power Started this topic · Evidence › Meta-analyses · 16 Jun 2026 · 4 likes On the subject in the title: Publication bias detection and its low power Working notes rather than a conclusion. I have seen SURMOUNT-1 ( N Engl J Med , 2022) cited in…
Follow-up: Sleep quality changes during weight loss Replied, post #39 · Wellbeing › Sleep · 7 Jun 2026 · 19 likes Appetite suppression and nighttime eating: if nighttime eating was a pattern, appetite suppression changes that pattern. Sleep can worsen if nighttime waking is…
Rotating between abdomen, thigh and upper arm: absorption differences — one year on Replied, post #68 · Practice › Administration · 26 May 2026 · 6 likes A genuinely late dose: the labelling generally says that if the next dose is more than a couple of days away, take it as soon as you notice. If the next dose is close,…
Insomnia at a dose step: reported experiences — the long version Replied, post #26 · Wellbeing › Sleep · 26 May 2026 · 11 likes When sleep problems need attention: if sleep does not improve as weight loss continues or if it worsens, discussing with a clinician is prudent. Sleep disorders are…
What I would want from a home test that does not exist yet — what changed since Replied, post #24 · Analytics › Home & field testing · 18 May 2026 · 1 like Sample handling matters: if a sample is contaminated or degraded before testing, the test gives you the result for the degraded sample, not for fresh material. That is…
The 2.5 mg starting dose is not a therapeutic dose — why that matters Replied, post #126 · Compounds › Tirzepatide · 16 May 2026 · 4 likes Dual agonism versus dose: how much of tirzepatide's effect is the GIP component and how much is simply achieving higher receptor engagement? The honest answer is that…
Step therapy requirements and how to satisfy them Replied, post #11 · Access › Insurance & coverage · 4 May 2026 · 0 likes Tier placement and step therapy: some formularies place a medication on a higher tier or require you to fail cheaper alternatives before approving the one you want.…
When a dose reduction is the correct response to a side effect Replied, post #17 · Practice › Dosing & titration · 2 May 2026 · 16 likes On post #13 — agreed on the reasoning, with one qualification. When a dose reduction is the correct response to a side effect: if a side effect is dose-dependent…
Five questions in one post gets you one answer — how to split them Replied, post #68 · Start Here › How to Ask · 30 Apr 2026 · 19 likes Coming back to post #66, because the follow-up matters more than the original answer. Asking a follow-up: new topic or reply in the old one? If the answer depends on…
Journal club: is percentage weight change the right endpoint? Replied, post #107 · Evidence › Journal club · 26 Apr 2026 · 14 likes This follows post #104 rather than contradicting it. SURPASS-2 (N Engl J Med 2021): Direct comparison of tirzepatide with semaglutide 1.0 mg. The 1.0 mg dose is not the…
Area percent versus weight percent: the confusion that causes most arguments Replied, post #6 · Analytics › HPLC & UHPLC · 26 Apr 2026 · 8 likes Column chemistry and particle size: smaller particles (1.7 μm) give better resolution and higher efficiency than larger particles (3.5 μm or 5 μm), at the cost of…
Getting a referral rather than a refusal Replied, post #10 · Clinical › Prescriber conversations · 11 Apr 2026 · 3 likes Prescription logistics: confirm whether it will be filled locally, requires mail order, or will be prescribed off-label and needs a compounding pharmacy. Different…
Cold solution and stinging: the simplest fix Replied, post #13 · Practice › Administration · 4 Apr 2026 · 16 likes Worth separating two things that post #9 runs together. Injection discomfort: comes from needle gauge (finer = less discomfort), volume (smaller = less discomfort),…
[2026 update] Are there stupid questions here? A staff answer, at length Replied, post #28 · Start Here › Welcome · 3 Apr 2026 · 3 likes Trust levels accumulate over time and they give you access to small things like the ability to edit your own posts without a timestamp. They are not a status symbol and…
Transporting a vial for a weekend away — a second dataset Replied, post #8 · Practice › Storage & stability · 16 Mar 2026 · 23 likes Picking up post #5: that is the part I would want checked first. Protecting from light: amber vials or opaque containers reduce light exposure. If you are storing for…
Why "dose equivalence" between different incretin analogues is a weak concept Replied, post #71 · Practice › Dosing & titration · 18 Feb 2026 · 0 likes Holding a dose indefinitely: the trials did not study indefinite holding at a non-maximum dose. The trials escalated to a target and then held that. What happens if you…
Pregnancy and pregnancy planning: contraindication and washout Replied, post #44 · Clinical › Special populations · 16 Feb 2026 · 27 likes I read post #42 twice before replying, because I had assumed the opposite. Hepatic impairment: less is known about dosing in significant liver disease than in kidney…
Second pass at: Identical chromatograms across two different lots Replied, post #6 · Sourcing › Red flags · 13 Feb 2026 · 0 likes Anonymity: a supplier that will not disclose legal name, address, or responsible person is not operating in a way that allows accountability.
Trifluoroacetate content and its consequences Replied, post #134 · Analytics › Impurities & related substances · 12 Feb 2026 · 21 likes Oxidation at methionine and tryptophan: adds 16 per oxygen. Usually elutes earlier. Oxidation is common in storage, especially if the solution is exposed to light or if…
Documenting a payment dispute without naming and shaming — the long version Started this topic · Sourcing › Payments · 6 Feb 2026 · 7 likes Posting this under the heading it deserves: Documenting a payment dispute without naming and shaming — the long version Everything below is what sits behind that. I…
Older adults, sarcopenia risk, and the trade-off nobody quantifies Replied, post #93 · Clinical › Special populations · 5 Feb 2026 · 3 likes post #92 is right about the mechanism and I think understates the practical bit. Renal impairment: the compounds are cleared renally to some degree. Dose adjustments…
Second pass at: Pregnancy and pregnancy planning: contraindication and washout Replied, post #94 · Clinical › Special populations · 26 Jan 2026 · 0 likes Coming back to post #92, because the follow-up matters more than the original answer. Adolescents: a distinct evidence base exists. The compounds are not approved for…
Second pass at: Pregnancy and pregnancy planning: contraindication and washout Replied, post #75 · Clinical › Special populations · 25 Jan 2026 · 0 likes Adolescents: a distinct evidence base exists. The compounds are not approved for routine adolescent obesity but are being studied. Adolescent physiology and psychology…
Pinch or no pinch, and how needle length changes the answer — the long version Replied, post #7 · Practice › Administration · 8 Jan 2026 · 24 likes Drawing up with one needle and injecting with another: a reasonable practice if you have extra needles. Fresh needle for injection reduces tissue drag and can decrease…
Coverage in the US: a map of the usual obstacles Replied, post #28 · Regional › North America · 27 Dec 2025 · 10 likes Regional variation in North America: access differs substantially by US state and Canadian province. Postcode is a major determinant of access.
Specificity, linearity, accuracy, precision, range, robustness — with real criteria — a… Replied, post #47 · Analytics › Method validation · 14 Dec 2025 · 1 like Stability-indicating method: one that can separate a compound from its degradation products. Critical for assay methods that claim to measure actual degradation (as…
Tracking a preprint to publication: a worked example Replied, post #97 · Evidence › Preprints · 10 Dec 2025 · 29 likes Check whether it was later published: searching for the preprint's first author and keywords in PubMed might find a published version. The published version is the…
DXA precision and the least significant change for lean mass Replied, post #47 · Outcomes › Body composition · 6 Dec 2025 · 8 likes Picking up post #44: that is the part I would want checked first. Changes during titration: measuring body composition during active titration is less useful than…
Warfarin and altered intake: the monitoring argument — the long version Replied, post #60 · Practice › Interactions · 1 Dec 2025 · 0 likes Alcohol: no absolute contraindication but it raises gastrointestinal irritation risk and this drug class already does that. The conservative position during titration…
Sequence verification for an obscure compound: how it is done — what changed since Replied, post #13 · Compounds › Other compounds · 22 Nov 2025 · 0 likes Practical note that does not fit anywhere else. Whatever you conclude from this topic, write down what you did and when. The single most useful thing in your own…
Follow-up: Why appetite effects are mostly central Replied, post #87 · Pharmacology › Receptor biology · 5 Nov 2025 · 22 likes Bias and desensitisation: receptors can be biased (preferentially activating some downstream pathways over others) and can desensitise over time (responding less to the…
Absolute versus relative contraindications Replied, post #3 · Safety › Contraindications · 4 Nov 2025 · 27 likes post #2 is right about the mechanism and I think understates the practical bit. Gastroparesis or severe delayed gastric emptying: these compounds slow gastric emptying.…
The anatomy of a question that gets answered within an hour — the long version Replied, post #14 · Start Here › How to Ask · 21 Oct 2025 · 0 likes Coming back to post #12, because the follow-up matters more than the original answer. Context that matters: compound, how long in, current dose, relevant history.…
Where to report an adverse event officially, by region — a second dataset Replied, post #14 · Safety › Adverse events · 12 Oct 2025 · 14 likes Pancreatitis is a genuine serious adverse event to know: severe epigastric pain, back pain, elevated lipase (≥3× upper limit of normal). If this constellation appears,…
Pinch or no pinch, and how needle length changes the answer Replied, post #93 · Practice › Administration · 4 Oct 2025 · 9 likes A site rotation scheme that actually works: abdomen, outer thigh, back of arm, outer hip. Rotate through them in order, move a minimum 2 cm between consecutive sites,…
Documentation that materially improves an appeal's chances Replied, post #12 · Access › Insurance & coverage · 28 Sep 2025 · 2 likes Coming back to post #10, because the follow-up matters more than the original answer. Reimbursement changes: a compound covered one year might not be the next. A…
Revisiting: Reading a denial letter as a specification for your appeal Replied, post #129 · Access › Insurance & coverage · 21 Sep 2025 · 1 like Coverage for weight management versus diabetes: many formularies cover these compounds for type 2 diabetes but not for weight management. The indication matters and…
About the Prescriber conversations category Replied, post #6 · Clinical › Prescriber conversations · 15 Sep 2025 · 5 likes post #5 answers the question as asked. The question underneath it is different. Understanding stopping rules: what would prompt stopping the compound? Adverse effect,…
Coming back to: What published stability data actually covers, and what it does not Replied, post #138 · Practice › Storage & stability · 12 Sep 2025 · 0 likes Dating prepared solutions: write the date reconstitution on the vial in permanent marker. If you later need to know whether it has been sitting for weeks or days, the…
Follow-up: History of disordered eating and why it changes the conversation Replied, post #72 · Clinical › Special populations · 1 Sep 2025 · 19 likes post #71 is right about the mechanism and I think understates the practical bit. Pancreatitis history: the compounds can rarely trigger pancreatitis. A history of…
Research-use-only labelling: what it means and what it does not Replied, post #25 · Sourcing › Regulatory · 23 Aug 2025 · 0 likes Picking up post #22: that is the part I would want checked first. Research-use-only status is a legal classification, not a safety classification. It means the compound…
Regional warehouse stock versus direct despatch Replied, post #10 · Sourcing › Logistics · 20 Aug 2025 · 21 likes Worth separating two things that post #6 runs together. Packaging integrity on arrival: if a parcel arrives with compromised packaging, that is evidence of a handling…
Column chemistry choices for a 40-residue peptide Replied, post #16 · Analytics › HPLC & UHPLC · 19 Aug 2025 · 10 likes Coming back to post #14, because the follow-up matters more than the original answer. Area percent is not mass percent. It is a proportion of absorbance, weighted by…
A request that was declined, and the reasoning — a second dataset Replied, post #67 · Documentation › Wiki requests · 12 Aug 2025 · 16 likes I read post #65 twice before replying, because I had assumed the opposite. Suggesting content for a page: if you know a maintained page is missing something important,…
Coming back to: A community side-effect dataset, with its response rate and biases Replied, post #5 · Data & Tools › Datasets · 27 Jul 2025 · 6 likes Bias toward positive outcomes: datasets collected by members are biased toward people who found the compounds useful. People who did not respond do not return. People…
Why oral semaglutide needs an absorption enhancer at all Replied, post #21 · Compounds › Oral incretins · 26 Jul 2025 · 0 likes On post #17 — agreed on the reasoning, with one qualification. Dose numbers for oral formulations are not comparable to injectable ones. The 14 mg oral dose is not…
Why one laboratory's 98.4% and another's 96.1% may not contradict Replied, post #11 · Analytics › Method validation · 26 Jun 2025 · 8 likes post #10 is right about the mechanism and I think understates the practical bit. Specificity: the method can distinguish the intended compound from related impurities…
Second pass at: Trial registration and comparing the protocol with the paper Replied, post #35 · Evidence › Trials · 15 Jun 2025 · 1 like On post #31 — agreed on the reasoning, with one qualification. Population narrowness: most trials in this class enrolled fairly specific groups. Baseline body mass…
[2026 update] An appeal that failed, and what I would do differently Replied, post #58 · Access › Insurance & coverage · 10 Jun 2025 · 0 likes Reimbursement changes: a compound covered one year might not be the next. A formulary decision in January can change by April. Checking again before refilling saves…
Counter-ion content and its effect on measured mass Replied, post #46 · Analytics › Mass spectrometry · 23 May 2025 · 29 likes Electrospray ionisation produces multiply charged ions. For a 4 kDa peptide you expect mostly 2+, 3+, and 4+ charge states. Reading an electrospray spectrum means…
Journal club: the CagriSema phase 2 combination paper — a second dataset Replied, post #4 · Evidence › Journal club · 13 May 2025 · 3 likes the opening post answers the question as asked. The question underneath it is different. SURMOUNT-1 (N Engl J Med 2022): Tirzepatide obesity trial. The largest mean…
A claim built entirely on a subgroup analysis Replied, post #30 · Evidence › Study critique · 12 May 2025 · 1 like Generalisability: do the inclusion/exclusion criteria narrow the population so much that results do not apply to real people asking about it? This is a fair criticism…
Water content on a certificate and why it changes the arithmetic Replied, post #17 · Analytics › COA interpretation · 10 May 2025 · 1 like Counter-ion form is crucial: peptides are isolated as salts, most often trifluoroacetate from reversed-phase purification or acetate after salt exchange. The…
SURMOUNT-4 and what withdrawal data does and does not tell an individual Replied, post #3 · Compounds › Tirzepatide · 3 May 2025 · 8 likes Two things before anyone answers the substance. First, the context in the first post is clear and specific. Second, the question is framed so that an answer can…
Journal club: STEP 1 and the treatment-policy estimand — does this still hold? Replied, post #107 · Evidence › Journal club · 22 Apr 2025 · 26 likes SURMOUNT-OSA (N Engl J Med 2024): Tirzepatide in obstructive sleep apnoea, using an objective physiological endpoint. Notable because soft endpoints are avoided. Two…
Second pass at: How to research a compound with no human data without deceiving yourself Replied, post #45 · Compounds › Other compounds · 22 Apr 2025 · 1 like Two things before anyone answers the substance. First, the context in the first post is clear and specific. Second, the question is framed so that an answer can…
[2026 update] Building a sensible monitoring schedule with your prescriber Replied, post #6 · Clinical › Bloodwork · 13 Apr 2025 · 16 likes Practical note that does not fit anywhere else. Whatever you conclude from this topic, write down what you did and when. The single most useful thing in your own…
Follow-up: Tesamorelin has an approved indication — what that changes about the evidence Replied, post #39 · Compounds › Secretagogues & GH axis · 8 Apr 2025 · 0 likes On post #35 — agreed on the reasoning, with one qualification. Why this subcategory is stricter about sourcing than most: the evidence base is weaker and that is…
Domestic fridge temperature mapping: a cheap experiment — what changed since Replied, post #73 · Devices › Cold chain · 25 Mar 2025 · 26 likes This follows post #70 rather than contradicting it. Shipping container and cold packs: reputable suppliers use insulated containers with cold packs designed to arrive…
Hepatic steatosis: what the MASH trial evidence supports Replied, post #5 · Clinical › Comorbidities · 20 Mar 2025 · 4 likes Cardiovascular disease: several compounds have cardiovascular outcome trials. SELECT was in people without diabetes; SUSTAIN 6 was in high-risk diabetes. Absolute…
One lot is one lot: when a report becomes a pattern — the long version Replied, post #55 · Sourcing › Vendor reports · 16 Mar 2025 · 3 likes Blind submission is worth the effort: have someone else relabel the sample so neither you nor the laboratory knows which supplier it came from until the result is back.…
Retatrutide dose escalation in the published trials Replied, post #16 · Compounds › Retatrutide · 15 Mar 2025 · 0 likes Picking up post #13: that is the part I would want checked first. Why this subcategory is more cautious than elsewhere: retatrutide is investigational, phase 3 is…
Biased agonism: a real phenomenon, an over-used explanation Replied, post #62 · Pharmacology › Receptor biology · 8 Mar 2025 · 0 likes Amylin receptor signalling: amylin promotes satiety and slows gastric emptying through a receptor distinct from GLP-1. The hypothesis behind combination therapy is two…
When "no data" is the complete and final answer Replied, post #108 · Compounds › Other compounds · 3 Mar 2025 · 0 likes post #107 is right about the mechanism and I think understates the practical bit. I disagree with the reply above, and I think the disagreement is substantive rather…
Why mass spectrometry cannot tell you about an epimer Replied, post #74 · Analytics › Mass spectrometry · 1 Mar 2025 · 11 likes Electrospray ionisation produces multiply charged ions. For a 4 kDa peptide you expect mostly 2+, 3+, and 4+ charge states. Reading an electrospray spectrum means…
Distinguishing a deletion sequence by mass alone Replied, post #118 · Analytics › Mass spectrometry · 22 Feb 2025 · 2 likes Purity and identity are different questions: LC-MS establishes that the species at a retention time has the expected mass. It does not establish how much of the sample…
Revisiting: What a well-designed human trial of a secretagogue would look like Replied, post #64 · Compounds › Secretagogues & GH axis · 2 Feb 2025 · 2 likes Evidence quality in the secretagogue literature is honestly weaker than in the incretin literature. Large randomised controlled trials are rare. Most evidence is…
A promotion I argued against, and why I lost Replied, post #68 · Documentation › Doc review · 20 Jan 2025 · 23 likes Practical note that does not fit anywhere else. Whatever you conclude from this topic, write down what you did and when. The single most useful thing in your own…
Follow-up: Individual participant data versus aggregate data Replied, post #89 · Evidence › Meta-analyses · 11 Jan 2025 · 0 likes On post #85 — agreed on the reasoning, with one qualification. Publication bias: what did not get published? Small studies with negative results are less likely to be…
Oxidation pathways for methionine and tryptophan Replied, post #47 · Analytics › Impurities & related substances · 29 Dec 2024 · 0 likes This follows post #44 rather than contradicting it. Incomplete deprotection: mass higher by the protecting group mass. Usually markedly later eluting. A synthesis…
Reading a supplementary appendix and finding the interesting part Replied, post #54 · Evidence › Trials · 28 Dec 2024 · 15 likes Worth separating two things that post #50 runs together. Intent-to-treat versus per-protocol: ITT includes everyone assigned regardless of whether they took the drug.…
Revisiting: Semaglutide formulation: what is in the licensed product besides the peptide Replied, post #24 · Compounds › Semaglutide · 21 Dec 2024 · 0 likes Two things before anyone answers the substance. First, the context in the first post is clear and specific. Second, the question is framed so that an answer can…
Follow-up: What this community means by "a source", in practical terms Replied, post #16 · Start Here › Welcome · 8 Dec 2024 · 0 likes Nothing here requires expertise. The experienced members here got that way by posting questions, not by knowing the answer before they showed up. If you know something…
Washout with a one-week half-life: the arithmetic Replied, post #46 · Research Methods › N-of-1 designs · 1 Dec 2024 · 21 likes post #45 answers the question as asked. The question underneath it is different. Generalisability: a robust n-of-1 result applies to you. It does not tell you much…
Coming back to: Preparing for an appointment: one page, three questions Replied, post #83 · Clinical › Prescriber conversations · 22 Oct 2024 · 23 likes This follows post #80 rather than contradicting it. Thank you for the correction. I have edited my earlier post with a note rather than silently, so the thread still…
Follow-up: A site rotation scheme that is easy enough to actually follow Replied, post #18 · Practice › Administration · 9 Sep 2024 · 0 likes A site rotation scheme that actually works: abdomen, outer thigh, back of arm, outer hip. Rotate through them in order, move a minimum 2 cm between consecutive sites,…
Circumference measurements as a poor man's composition estimate Replied, post #11 · Outcomes › Body composition · 21 Jul 2024 · 2 likes Having read the exchange above, I think I was wrong earlier in this topic and I want to say so plainly rather than quietly editing. The correction was fair and I had…
The mass-error checker and its intended scope Replied, post #78 · Data & Tools › Calculators · 26 Jun 2024 · 30 likes Having read the exchange above, I think I was wrong earlier in this topic and I want to say so plainly rather than quietly editing. The correction was fair and I had…
Coming back to: Preparing for an appointment: one page, three questions Replied, post #10 · Clinical › Prescriber conversations · 23 Jun 2024 · 4 likes On post #6 — agreed on the reasoning, with one qualification. Discussing side effects: be specific. "Nausea" is less useful than "I have nausea worst 24 to 36 hours…